-+ 0.00%
-+ 0.00%
-+ 0.00%

TD Cowen Maintains Buy on Teva Pharmaceutical Indus, Raises Price Target to $57

Benzinga·11/04/2026 19:35:42
Listen to the news
TD Cowen analyst Joseph Thome maintains Teva Pharmaceutical Indus (NYSE:TEVA) with a Buy and raises the price target from $55 to $57.